Skip to main content

Table 6 Overall survival of the patients with colorectal cancer grouped by CEA levels

From: Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen

CEA level (ng/mL)

Overall survival (months)

P

PPTR group

Non-PPTR group

0–5

26.13 (2.80–86.73)

16.83 (2.80–64.50)

0.032

5.1–18

20.90 (2.77–70.30)

14.80 (5.73–41.33)

0.011

18.1–70

19.70 (2.87–63.17)

11.85 (2.33–36.63)

0.002

>70

19.57 (4.70–73.33)

14.17 (3.47–44.43)

0.186

  1. Each value is presented as median followed by range in parentheses
  2. The overall survival was compared between PPTR and non-PPTR group, and the differences were analyzed using the log-rank test
  3. CEA carcinoembryonic antigen, PPTR palliative primary tumor resection
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us